Comprehensive analysis of the role of ICOS ( CD278 ) in pan-cancer prognosis and immunotherapy.

Xiashuang ZhaoYongfeng WangXianglai JiangBangqian MoChenyu WangMingzheng TangYao RongGuiqian ZhangMing HuHui Cai

Published in: BMC cancer (2023)

This study suggests that ICOS may be a potential tumor immunotherapy target and prognostic marker.

Keyphrases